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Despite dedicated nation-wide efforts to raise awareness against the harmful effects
of fast-food consumption and sedentary lifestyle, the Arab population continues to
struggle with an increased risk for metabolic disorders. Unlike the European population,
the Arab population lacks well-established genetic risk determinants for metabolic
disorders, and the transferability of established risk loci to this population has not been
satisfactorily demonstrated. The most recent findings have identified over 240 genetic
risk loci (with ∼400 independent association signals) for type 2 diabetes, but thus far
only 25 risk loci (ADAMTS9, ALX4, BCL11A, CDKAL1, CDKN2A/B, COL8A1, DUSP9,
FTO, GCK, GNPDA2, HMG20A, HNF1A, HNF1B, HNF4A, IGF2BP2, JAZF1, KCNJ11,
KCNQ1, MC4R, PPARγ , SLC30A8, TCF7L2, TFAP2B, TP53INP1, andWFS1) have been
replicated in Arab populations. To our knowledge, large-scale population- or family-based
association studies are non-existent in this region. Recently, we conducted genome-wide
association studies on Arab individuals from Kuwait to delineate the genetic determinants
for quantitative traits associated with anthropometry, lipid profile, insulin resistance, and
blood pressure levels. Although these studies led to the identification of novel recessive
variants, they failed to reproduce the established loci. However, they provided insights
into the genetic architecture of the population, the applicability of genetic models based
on recessive mode of inheritance, the presence of genetic signatures of inbreeding due
to the practice of consanguinity, and the pleiotropic effects of rare disorders on complex
metabolic disorders. This perspective presents analysis strategies and study designs
for identifying genetic risk variants associated with diabetes and related traits in Arab
populations.
Keywords: Arab population, type 2 diabetes, genome-wide association studies, risk loci, Kuwait, Euro-centric risk
variants, genetics, epigenetics
BACKGROUND
Discovery of oil reserves in the Arabian Gulf since the 1930s increased overall wealth in these
countries. Rapid socioeconomic transitions in Arab countries in the rich post-oil era marked
changes in the nutritional patterns and food habits, including a shift from locally grown natural
products to a Western diet and change from nomadic way to urbanized life. These resulted in
an increasingly sedentary lifestyle and wide-spread obesity (1–3) and an increased prevalence of
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diabetes (4, 5), and metabolic syndrome (6) in the last few
decades. Diabetes is sweeping through Middle East; as per the
International Diabetes Federation Atlas 8th Edition for 2017, the
age-adjusted comparative prevalence of diabetes (18–99 years) in
the Middle East and North Africa region is 10.5%, which is the
second highest after the North America and Caribbean region.
Up to 30% of native adult hospital visitors in Kuwait are afflicted
with T2DM (4). The prevalence among adults in the countries
from the Peninsula (Kingdom of Saudi Arabia 31.6%, Oman 29%,
Kuwait 25.4%, Bahrain 25.0%, and United Arab Emirates 25.0%)
are significantly associated with high per capita GDP (gross
domestic product) and energy consumption (7). T2DM results
from a complex interplay of adverse lifestyle exposures and
genetic predisposition. Despite the high prevalence of T2DM,
the Arab population lacks convincingly determined T2DM
genetic risk variants and reports that sufficiently demonstrate the
replication of established risk variants.
Identified T2DM Risk Loci in Arab
Population Compared With Established
Gene Loci
Since the advent of genome-wide association (GWA) studies,
many T2DM risk loci have been globally identified, which
concentrated mainly on the European and Asian populations.
A recent study by Mahajan et al. (8), that combined data from
32 European-descent GWAS imputed to high-density reference
panels, identified 243 genome-wide significant T2D-risk loci with
403 independent association signals. Therefore, it is important to
understand the relevance and performance of these established
loci in the Arab population and how often such novel risk loci
are identified in this population. Published reports on T2DM
genetics in the Arab population originate from Kuwait, Lebanon,
Saudi Arabia, Qatar, UAE, Oman, and Tunisia (Table 1). Some of
these studies illustrate certain overlaps with established T2DM
risk loci, some illustrate the complete absence of any overlap
(Table 1), and some identify novel risk loci. Approximately 25
established T2DM loci (ADAMTS9, ALX4, BCL11A, CDKAL1,
CDKN2A/B, COL8A1, DUSP9, FTO, GCK, GNPDA2, HMG20A,
HNF1A, HNF1B, HNF4A, IGF2BP2, JAZF1, KCNJ11, KCNQ1,
MC4R, PPARγ , SLC30A8, TCF7L2, TFAP2B, TP53INP1, and
WFS1) and few established obesity loci (ADIPOQ, FTO, RFX7,
and USP37) are observed to replicate in the Arab population
(Table 1). The replicated T2DM risk loci fall into three categories
(Table S1): (i) those that impact the T2DM risk through impaired
β-cell function (ALX4, BCL11A, CDKAL1, CDKN2A/B, GCK,
HNF1A, HNF1B, HNF4A, IGF2BP2, JAZF1, KCNJ11, KCNQ1,
SLC30A8, TCF7L2,WFS1); (ii) those that act throughmodulating
insulin action (ADAMTS9, DUSP9, PPARγ ); and (iii) those that
were primarily associated with BMI, obesity and adiposity but
subsequently identified also as affecting T2DM risk through
insulin action (FTO, GNPDA2, MC4R, TFAP2B).
Studies illustrating a replication of established risk loci in
Arab population are generally based on targeted genotyping,
whereas those failing to observe the established loci are GWA-
based. GWA studies for quantitative traits in the Arab population
in Kuwait were unsuccessful to demonstrate established loci at
genome-wide significance but instead led to identification of
novel risk loci (Table 2); these identified novel loci are often
reported in literature as associated with biological processes
relating to the T2D traits (Table S2). Moreover, even at
nominal p-values, very few established markers are identified
in the data sets in the Kuwaiti population (Table 2—Items V–
VI). The exemplary susceptibility gene loci namely, PPARγ ,
KCNJ11, TCF7L2, SLC30A, ABCC8, HHEX, CDKN2A, IGF2BP2,
CDKAL1, and FTO, known to be well-replicated in other
ethnic population groups were not identified in our studies on
the Kuwaiti population. Similarly, only two established T2DM
risk gene loci namely (CDKAL1 and TCF7L2) were identified
using an imputed data set of 5,000,000 single nucleotide
polymorphisms (SNP) in the Lebanese population, which has
a higher affinity to European populations compared with other
Middle Eastern populations (21). It was also observed that
the established markers do not necessarily replicate among
inter-Arabic population groups. For example, Mtiraoui et al.
(17) (Table 1) illustrated differences between the Levant Arabs
(from Lebanon) and north African Arabs (from Tunisia) by
demonstrating the association of TCF7L2 in both groups,
IGF2BP2 and PPARγ exclusively in the Lebanese group, and
KCNJ11 and SLC30A8 exclusively in the Tunisian group.
The partial overlap of established markers and differential
replication of established markers in inter-Arabic populations
along with the identification of novel loci are also observed in
case of other complex disorders, such as rheumatoid arthritis,
myocardial infarction/coronary artery disease, prostate cancer,
and breast cancer (37–40). It is highly interesting to perform
genetic association studies in ethnic populations such as Arabs,
not only to re-confirm findings from other ethnic groups but
since they may also lead to identification of novel T2DM risk loci.
POSSIBLE CAUSES FOR OBSERVED
DIFFERENCES IN THE RISK LOCI
PROFILES
Study Cohorts
The above-mentioned observations in Arab populations are
associated with the size of study cohorts used in the studies,
which is considerably lower than those used conventionally in
global GWA studies (Table 1). This deficit affects the strength
of the studies and leads to issues such as non-consideration
of markers that have become rare in Arab populations. Other
shortcomings of the study designs are inconsistencies (such as in
age) between case and control cohorts and the failure to include
in the set of markers tested for replication those that are in LD
with established markers.
Differences in Phenotype Profiles Between
Arab and Global Populations
While most of the well-characterized T2DM genes appear to
be associated with β-cell dysfunction, diabetes observed in the
Arab population is supposedly associated with obesity. This is
underlined by the following observations in the Arab population:
the prevalence of obesity in T2DM patients is high (41), Arab
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TABLE 1 | Studies on T2DM risk loci from the region and comparison with established T2DM loci.
Study Testing of established loci or
general GWAS study; Study
population




Li-Gao et al. (9) Tested 122 T2DM risk variants
(from 84 loci) in Saudi Arabian
population
659 T2DM cases and
919 controls
Absence of any overlap: None of the
tested markers was replicating at p-value
corrected for Bonferroni threshold
(0.05/122). At p < 0.05, 11 were seen
replicating
Failure to replicate any of the tested
122 risk variants was attributed to low




Osman et al. (10) Tested established loci (BMI:87;
WC:58; obesity with T2DM:145)
in UAE Arab population
880 BMI cases; 455
WC cases; 464 T2DM
cases and 415 contols
Partial overlap and novel loci:
Replicates FTO, USP37, and RFX7 ( for
obesity) and TCF7L2 and MC4R ( for
T2DM). Also reports novel associations
KCNK3 and RARB for T2DM
Could replicate very few established
obesity and T2DM loci; the study
could identify few novel associations
for T2DM in Arabs
Cauchi et al. (11) Tested 44 variants from 37
established loci for T2DM in
North African Arabs (Morocco
and Tunisia)
1,193 T2DM cases and
1,055 controls from
Morocco. Associations
were then assessed in
1,446 T2DM cases and
942 controls from
Tunisia
Partial overlap: 13 of 37 established
gene loci confirmed in Moroccans and
Tunisians. BCL11A, ADAMTS9, IGF2BP2,
WFS1, CDKAL1, TP53INP1, CDKN2A/B,
TCF7L2, KCNQ1, HNF1A, FTO, MC4R,
and GCK.
Concludes sharing of T2DM risk loci
between Europeans and North
African Arabs
O’Beirne et al. (12) Tested 37 variants from 29
established T2DM gene loci, and
an additional 27 tag SNPs in
Qatari population
1,124 T2DM cases and
590 controls
Partial overlap: Only TCF7L2 of the
tested 29 loci was seen replicating in
Qatari population
Concludes that the genetic risks for
T2DM are likely different in Qataris
compared to Europeans and Asians
Al-Daghri et al. (13) Tested 28 established T2DM loci
in Saudi Arabian Population
1,166 T2DM cases and
1,235 controls
Partial overlap: Replicates 9 of the 28
tested established T2DM loci of TCF7L2,
WFS1, JAZF1, SLC30A8, CDKN2A/B,
KCNQ1, HMG20A, HNF4A, and DUSP9
Concludes overlap in T2DM risk loci
across ethnicities irrespective of
prevalence
Tomei et al. (14) Tested 23 established
obesity-related loci in Qatari
population
804 Qatari individuals Partial overlap: Could identify only two
(TFAP2B and GNPDA2) of the tested 23
obesity loci
Concludes a different genetic profile
associated with obesity in the Qatari
population compared to Western
populations
Almawi et al. (15) Tested 19 SNPs in/near 15
established T2DM loci in
Lebanese Levant population
995 T2DM cases and
1,076 controls
Partial overlap: 4 (COL8A1, KCNQ1,
ALX4, HNF1B) of the 15 established loci
were seen associated with T2DM in
Levants. The authors have shown in their
previous works replicability of IGF2BP2,
CDKAL1, TCF7L2.
Concludes that insufficient power as
the reason for the inability to detect all
the tested loci in Levants





HHEX in Omani Arabs
992 T2DM cases and
294 controls
Partial overlap: Only four of the 9 tested
loci could be replicated—KCNJ11,
TCF7L2, CDKAL1, CDKN2A/B
Suggests large-scale studies, other
than case-control design, to detect
rare variants that might explain the
missing heritability
Mtiraoui et al. (17) Tested 7 established T2DM loci -
ENNP1, IGF2BP2, KCNJ11,
MLXIPL, PPARγ , SLC30A8, and
TCF7L2 in Levant Arabs from
Lebanese and North African
Arabs from Tunisia
Lebanese: 751 T2DM
cases and 918 controls
Tunisia: 1,470 T2DM
cases and 838 controls
Partial overlap with established
markers and differences in overlap
between the two Arab popualtions:
TCF7L2 was replicating in both; IGF2BP2
and PPARγ were replicating in Lebanese
and not in Tunisia; KCNJ11, and SLC30A8
were replicating in Tunisia but not in
Lebanese. Neither ENNP1 nor MLXIPL
was seen replicating in Lebanese or
Tunisians.
Concludes differences in replicability
of T2DM loci between Lebanese and
Tunisians as well as between Europe




between the MTHFR SNPs
(C677T and A1298C) and T2DM
in Emirati Arabs
169 T2DM cases and
209 controls
Absence of any overlap: MTHFR gene
polymorphisms are not related to T2DM in
the Emirati population
Could not establish MTHFR variants
as risk variants for T2DM in Emirati
population
(Continued)
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TABLE 1 | Continued
Study Testing of established loci or
general GWAS study; Study
population
Sample size Replicates known markers or
identifies novel markers?
Conclusions
Al Safar et al. (19) Tested the T2DM risk
loci—TCF7L2 (rs10885409) and
PPARγ2 (rs1801282) in Arab
Emirati population
272 T2DM cases and
216 controls
Partial overlap: Confirms the association
of the TCF7L2 variant but not PPARγ2 as
a T2DM loci in UAE Arabs
Confirms one of the two established
markers as T2DM loci; and the other
established marker as NOT a T2DM
loci
Khan et al. (20) Tested the established obesity
loci—FTO (rs9939609) and VDR




Partial overlap: Replicates the FTO
marker as adult obesity risk loci in UAE.
VDR could not be replicated
No significant association is seen in
UAE population for the established
marker from VDR
POPULATION-BASED GWA AND FAMILY-BASED STUDIES
Ghassibe-Sabbagh
et al. (21)
Performed GWAS (on genotyped




Partial overlap and Novel loci: Only two
established loci (CDKAL1 and TCF7L2)
surfaced
Concludes that the replication of
established markers in Lebanese
population is less than expected
Al Safar et al. (22) Performed family-based GWAS
for T2DM in UAE Arabs
Discovery cohort: N =
178 (66 cases, 112
controls); Replication
cohort: N = 315 (116
cases and 199
controls)
Novel loci: Identified novel associations
(KCTD8, PRKD1, GABRA2, GABRA4, and
GABRB1)
Did not identify any of the established
gene loci
Zadjali et al. (23) Family-based study (“Oman
Family Study”) to investigate the
association of SNPs
(rs17300539 and rs266729) from
adiponectin gene ADIPOQ with
obesity traits in Oman
328 Arabs in one large
extended family from
Oman
Showed family-based evidence for
association of one (rs266729) of the two
tested SNPs from ADIPOQ defining
obesity in Arab population
Concludes that ADIPOQ as obesity










Identified novel associations for metabolic
traits
Only three established markers from
CETP and STARD3 are seen at
borderline p-values
studies often find obesity-related genetic loci (e.g., ADIPOQ
gene) to contribute to the genetic risk of T2DM in Arab
populations (10, 23, 42, 43), and established T2DM-related SNPs
are seen associated with obesity phenotypes in Arabs (44).
High Rate of Consanguinity and
Prevalence of Rare, Mendelian, and
Familial Disorders in Arab Populations
Marriages in Arab populations are traditionally often
consanguineous (45, 46). An increased risk of T2DM has
been observed among the offspring of such consanguineous
marriages in Saudi Arabia and Qatar (47, 48). The familial
clustering of T2DM has been reported in Arab populations
from Morocco (49), Tunisia (50), Oman (51), and Qatar (52).
Additionally, Arab populations exhibit many rare, Mendelian,
and familial genetic disorders. Blair et al. (53) identified
thousands of associations between Mendelian and complex
diseases in the medical records of over 110 million patients from
USA and revealed a non-degenerate, phenotypic code that links a
complex disorder to a unique collection of Mendelian loci. Using
GWA studies, they further demonstrated that common variants
associated with complex diseases are enriched in the genes
indicated by this “Mendelian code.” Thalassemia, cystic fibrosis,
Huntington’s disease, and Friedreich’s ataxia are examples of
rare disorders that increase patient’s pre-disposition to diabetes
(54–58). Examples of T2DM risk genetic loci, which are also
associated with rare recessive disorders, are LIPC (Hepatic
lipase deficiency), PDX1 (Pancreatic agedness 1), ENPP1
(Hypophosphatemic rickets, also associated with obesity),
WFS1 (Wolfram syndrome 1), and SLC2A2 (Fanconi-Bickel
syndrome). Table 2 summarizes OMIM disease annotations,
from the OMIM (Online Mendelian Inheritance in Man) catalog
of human genes and genetic disorders (59), for risk loci that
were identified for metabolic traits in Kuwaiti Arab populations.
The genetic locus OTX2-AS1 associated with hypogonadism
is particularly interesting as literature reports have provided
hints regarding the connection between hypogonadism and
T2DM in Arab consanguineous families (60, 61). Al Hayek et al.
reported that 36.5% men with T2DM from Jordan had low
serum testosterone levels; 17% of such T2DM patients with low
serum testosterone levels had primary hypogonadism, whereas
the remaining had secondary hypogonadism (62). A study based
on Saudi Arabian population revealed a significantly higher
positive family history of schizophrenia in patients with first or
second cousin parents (63). An increased prevalence of T2DM
has been observed in patients with schizophrenia (SCZ); the
co-occurrence of SCZ and T2DMmay partly be driven by shared
genetic factors (64) such as cell adhesion molecules (65, 66).
Furthermore, the QDiabetes-2018 model (used within the UK
National Health Service) (67) now includes schizophrenia,
learning disabilities, use of atypical antipsychotics, treated
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TABLE 2 | Risk variants identified in our previous studies on Arab individuals from Kuwait.
Metabolic traits Gene loci /variant Model; p-value; Beta value for associations OMIM annotation for the gene (where available)
I. OBESITY TRAITS (25)
Waist Circumference
(WC)
TCN2/rs9606756 Additive; 1.46E-07 (9.46E-08
upon correction for medication);
4.815
Transcobalamin II deficiency (AR)
(PMIM: 275350)
II. BLOOD PRESSURE TRAITS (27)
Systolic Blood
Pressure (SBP)
MC3R/rs3827103 [Val81Ile] Additive; Sequencing the genes.
0.01; 4.9
Mycobacterium tuberculosis,
protection against; (PMIM: 607948);
Obesity, severe, susceptibility to,
BMIQ9; (PMIM: 602025)
III. METABOLIC TRAITS (26)
Glycated
hemoglobin (HbA1c)





OTX2 with Microphthalmia, syndromic
5 (AD) (PMIM: 610125); Pituitary
hormone deficiency, combined, 6 (AD)
(PMIM: 613986); Retinal dystrophy,
early-onset, with or without pituitary
dysfunction (AD) (PMIM: 610125).
AS1 with susceptibility to Asthma
(PMIM: 607277)
Triglyceride (TG) PLGRKT/rs17501809 Recessive; 1.04E-07; 1.807
Triglyceride (TG) LOC105376072/ rs11143005 Recessive; 4.03E-07; 0.419
Triglyceride (TG) IGF1/rs10860880 Recessive; 2.07E-07; 1.596 Growth retardation with deafness and
mental retardation due to IGF1
deficiency (AR) (PMIM: 608747).
Decreased IGF-1 secretion occurs in
the majority of the thalassemia
patients particularly those with growth
and pubertal delay (28). Thalassemia
is recessively inherited
Triglyceride (TG) [THSD4, NR2E3]/ rs900543 Recessive; 1.27E-07; 1.625 NR2E3 with Enhanced S-cone
syndrome (AR) (PMIM: 268100);
Retinitis pigmentosa 37 (AD,AR)
(PMIM: 611131)







6.517/1.64E-08; 8.315 (for FPG)
Triglyceride (TG) LAD1/rs11805972 Recessive; 2.16E-17; 8.485 Leukocyte adhesion deficiency (AR)
(PMIM: 116920)
Triglyceride (TG) OR5V1/rs7761746 Recessive; 1.31E-09; 6.006
Triglyceride (TG) [CTTNBP2, LSM8]/rs39745 Recessive; 1.57E-08; 5.643
Triglyceride (TG) PGAP3/rs2934952 Recessive; 1.16E-09; 6.086 Hyperphosphatasia with mental
retardation syndrome 4 (AR) (PMIM:
615716)
Triglyceride (TG) [RP11-191L9,CERK]/rs9626773 Recessive; 7.47E-15/7.776
Triglyceride (TG) ST6GALNAC5/rs10873925 Recessive; 4.11E-08/0.633
Triglyceride (TG) SPP2_ARL4C/rs4663379 Recessive; 8.38E-09/1.841
Triglyceride (TG) NPY1R/rs10033119 Recessive; 8.79E-09/2.698
Triglyceride (TG) LINC00911_FLRT2/rs17709449 Recessive; 5.12E-08/1.173
Triglyceride (TG) CDK12-NEUROD2/ rs11654954 Recessive; 2.18E-08, 0.9881
Triglyceride (TG) STARD3/rs9972882 Recessive; 1.81E-08, 0.7284
(Continued)
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TABLE 2 | Continued
V. ESTABLISHED MARKERS (AT GENOME-WIDE SIGNIFICANCE IN GWAS CATALOG) APPEARING IN KUWAITI DATA SET AT NOMINAL p-VALUES FOR
ASSOCIATION






rs3764261/CETP Additive; 1.10E-05 (KWT)—reached
4.64E-08 under joint analysis.
1E-769 [European, East Asian, South
Asian and African ancestry (30)]
High-Density
Lipoprotein (HDL)
rs1864163/CETP Additive; 4.64E-06 (KWT)—reached
1.15E-08 under joint analysis.
7E-39 [FUSION, SardINIA, Diabetes
Genetics Initiative studies; also, in




rs1800775/CETP Additive; 4.99E-06 (KWT)—reached
5.51E-08 under joint analysis.
4E-93 [Europeans and Filipinos (32)]
Triglyceride (TG) rs9972882/STARD3 Additive; 4.07E-07 (KWT)
An LD marker rs1877031/ STARD3 is
an established marker in East Asians
for the related trait of HDL at 1E-21
[East Asians (30)]
VI. ESTABLISHED MARKERS (AT SUGGESTIVE p-VALUES IN GWAS CATALOG) APPEARING IN KUWAITI DATA SET ALSO AT NOMINAL p-VALUES FOR
ASSOCIATION
Triglyceride (TG) rs900543/[THSD4,NR2E3] Recessive; 2.26E-07; 1.625 (KWT).
9.40E-05; 0.036 [Europeans (33)]
Fasting insulin
Triglyceride (TG) rs11143005/LOC105376072 Recessive; 3.218E-07; 0.420 (KWT).




Recessive; 6.963E-06; 0.773 (KWT)





Additive; 3.65E-06; 0.2037 (KWT)
9.80E-05; NA [Europeans (36)] Serum
ratio of Arabinose fructose
hypertension, and polycystic ovary syndromes as additional risk
factors.
ANALYSIS STRATEGIES FOR GWA
STUDIES IN ARAB POPULATIONS
The current analysis strategies for GWA studies in Arab
populations and suggested extensions are presented in Figure 1
and are discussed below.
Participant Recruitment and Sample Size
The sample size has a linear relationship with the number of
identified risk loci; a plateau has not been observed for any
trait to date (68). Recruiting the required large number of
participants from the intended sample population continues
to be challenging in Arab countries (69, 70). Clinical research
in Arab countries experiences a lack of public outreach
capabilities and coordination between research institutes and
hospitals or Ministries of Health. This challenge can be
circumvented by understanding public perception and attitude
toward medical research and by seeking out means to increase
public trust and awareness of clinical research in the Arab
population.
The optimum sample size is determined by various factors
including homogeneity seen in the population, prevalence of the
disorder, variance in the trait measurements, genetic models used
in the association tests, number of markers tested in the study,
allele frequencies of the risk variants, effect sizes, genome control
inflation rates, desired Type I error rates, type of study design
(quantitative trait association, case-control studies with unrelated
individuals or family-based trios, or sibling case-control designs)
(71, 72). A number of tools are available to calculate the
optimum sample size; some of the tools often used include
Genetic Association Study (GAS) Power Calculator for one-stage
genetic association studies http://csg.sph.umich.edu/abecasis/
cats/gas_power_calculator/; (73), CaTS Power calculator http://
csg.sph.umich.edu//abecasis/CaTS/index.html; (74) for two stage
genome wide association studies; Quanto for various study
designs (including the matched case-control, case-sibling, case-
parent, and case-only designs) http://biostats.usc.edu/Quanto.
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FIGURE 1 | Current analysis strategies and suggested extensions for GWA studies in Arab populations.
html; (75), and QpowR for two-stage study design with unrelated
individuals https://msu.edu/~steibelj/JP_files/QpowR.html.
Differences in the Extent of Inbreeding
Among Subgroups in the Arab Population
The rate of consanguinity and the extent of resultant inbreeding
differ among Arab countries as well within a single country.
For example, among the three genetic substructures of Kuwaiti
Arab population (76–79), the subgroups of Saudi Arabian
tribe ancestry and Persian ancestry exhibit high inbreeding
coefficients (0.04226 and 0.025742, respectively) indicating
endogamy, whereas the nomadic Bedouin subgroup exhibits
lower inbreeding coefficient (0.00274), indicating heterogamy
(76). Similar observations have been made with population
substructures in Qatar (80). The genetic heterogeneity between
the subgroups warrants subgroup-specific genetic association
analysis using large sample sizes, particularly for those with
higher rates of inbreeding.
Comorbid Conditions as Confounders
Diabetes is often comorbid with other complex chronic
disorders (81); Most prevalent comorbid disorders, that occur
in “concordant” form wherein both disorders represent parts
of the overall identical pathophysiological risk profile, include
hypertension, coronary artery disease and peripheral vascular
disease (82). An example for comorbid disorders being
influenced by unique environmental factors is an increased
risk for diabetes in patients with learning disabilities, physical
or sensory disabilities, and mental health problems. The co-
occurrence of schizophrenia and diabetes may partly be driven
by shared genetic factors (64). Comorbidities can also be
consequences of hyperglycemia. Tests for genetic associations
need to consider comorbid conditions. For advancements in
metabolic disorder research in the Arabian Peninsula, the
identification of overlaps between metabolic disorders and rare
genetic as well as common disorders from existing literature
and the formation of a catalog of causal factors/markers for
overlapping traits are immediately required. A careful and
extensive phenotyping in relation to rare and less frequent
disorders must be prioritized during sampling. These variables
can be further used as covariates in association tests.
Genetic Models Based on Recessive Mode
of Inheritance for Association Tests
Consanguinity in successive generations cumulatively increases
inbreeding levels, recessive alleles, and the proportion of
homozygous gene regions in Arab populations (76, 83). An
overwhelming proportion (63%) of the disorders documented in
the Catalog for Transmission Genetics in Arabs (CTGA) (84)
follows a recessive mode of inheritance. Therefore, it is not
surprising to observe that the risk variants reported in our studies
appeared when the genetic model based on a recessive mode of
inheritance was used (Table 2), and majority of the risk variants
were observed to be harbored in the runs of homozygosity (ROH)
segments (24). However, when established markers appeared in
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the Kuwaiti population data sets, it was invariably when the
association tests used additive models. It is obvious that genetic
pre-disposition of T2DM is not a recessive disorder, although
in certain populations homozygosity of susceptibility alleles can
further increase the population prevalence of the disease. It is
recommended that population genetics in the Arab region use
recessive models in addition to additive models, especially when
large number of homozygous segments and/or of recessive risk
genotypes are observed in sufficiently large number of individuals
in the study cohort.
Estimation of Acceptable Effect Size
Large sample sizes enable the identification of causal variants
with small effect size in GWA studies. Although the estimation
of sample sizes for a 2-stage design (discovery phase followed
by replication) is generally strictly followed in GWA studies,
the estimation of a true effect size explainable by sample size
is not strictly followed in several studies; the proper selection
of associated variants in the discovery phase is not usually
difficult, mainly because the use of additive models (wherein both
heterozygote + rare homozygous genotypes are tested against
reference homozygous genotypes with additive effect) does not
unusually inflate the effect size values for common markers.
However, in case of the recessive model, variants that show ≥5%
frequency (i.e., associated with few rare homozygous genotypes)
can show unusually large effect sizes. Therefore, an estimation of
the acceptable effect size for a desired percentage of variance in a
given trait (mean ± SD) and sample size at 80% power is pivotal
for restricting SNP associations from undesirable high effect size
and inappropriate p-values resulting from recessive effect.
Joint Analysis—Combining Results From
Discovery and Replication Phases
GWA studies follow a 2-stage design irrespective of addressing
quantitative or binary trait association. A strategy involving
the joint analysis of data from both stages, which is currently
increasingly used, has been advocated to result in an increased
capability of detecting genetic associations (74). Such a meta-
analysis increases the capacity for detecting weak genotypic
effects. An example of the resultant increased power is observed
in the case of three established markers from CETP (rs3764261,
rs1864163, and rs1800775), which do not attain genome-wide
significance in discovery cohort of our studies but in joint
analysis (Table 2—Item V).
Heteroscedasticity and Trait
Transformation
Quantitative traits (associated with complex disorders)
used in association studies often violate the assumption of
normality. Methods commonly used to handle non-normal
traits include natural logarithm and rank-based inverse-
normal transformations (85). Although the merits of such
transformations are questionable (86), their use has been
increasing. Elaborate assessments regarding the extent to which
such transformations mask the true phenotype variability are
lacking in literature. Owing to high inbreeding and prevalence of
autosomal recessive disorders in the Arab population (87), the
segregation of rare homozygous alleles may exert relatively larger
effects on quantitative trait variations. Hence, earmarking any
outlying data dispersion as heteroscedastic may conceptually be
incorrect. Furthermore, performing trait transformations may
adversely mask the actual effects of such loci on the variation of
quantitative traits. Thus, to avoid any false positive or negative
associations, it is advised to perform association tests, using
appropriate genetic models, with both the raw and transformed
traits, and to simultaneously adjust the models for disorders
(rare and common) that overlap with the metabolic syndrome.
Relatedness and Loss of Samples
The imprecise modeling of genetic relatedness and population
stratification among study subjects results in a substantial
inflation of test statistics and spurious associations. Moreover,
randomized sample sets in the Arab population exhibit rich
relatedness due to the prevalent practices of polygamy and
consanguinity. Therefore, detailed quality control procedures for
relatedness and admixture must be performed in case of Arab
studies. Relevantly, our studies are performed using the following
steps: (i) assessment of relatedness among participants to the
extent of third-degree relatives and removal of one sample per
pair of related participants, (ii) performing ancestry estimations
using ADMIXTURE (88) and removal of samples with abnormal
deviations to the extent of component ancestry elements that
have been previously established for the three Kuwaiti population
subgroups (76), and (iii) delineation of principal components
using EIGENSTRAT (89) and removal of outlying samples. These
exhaustive steps, aimed at reducing false positive findings, lead
to huge loss of samples. Thus, although the use of unrelated
individuals in GWA studies is a norm, the use of recent
sophisticated algorithms [such as BLOT-LMM (90) FaST-LMM
(91), EMMAX (92)], which account for kinship structures and
ancestries within a sample set, may offer larger power to the study
by retaining more samples.
Quantitative Trait Association Studies
Using “All” Diabetic Cohort
Quantitative trait association studies are usually conducted
in population-based cohorts comprising both people with
diabetes and diabetes-free individuals at the time of participant
recruitment. Association tests are usually adjusted for obesity,
diabetes, and medication regimen. However, it is important to
extend the studies to cohorts comprising entirely of diabetic or
prediabetic participants so that the prospects for use of identified
genetic determinants in diabetes care and treatment become
promising (93).
Case for Whole-Genome Homozygosity
Association (WGHA) Methodologies
High inbreeding within the Arab population renders it a
promising repository for providing a large scope for discovery
of ROH and segments of identity by descent (IBD). ROH
indicates an ancient shared common ancestry, whereas IBD
indicates a recent ancestry. Both traits are reportedly effective in
delineating population demography and recessive components of
Mendelian and complex phenotypes (76). The risk loci identified
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in our studies often overlay ROH regions, some of which are
“novel.” Currently, a promising new concept of “whole-genome
homozygosity association (WGHA) methodology” in identifying
genetic susceptibility loci harboring recessive variants (94) is
being developed. Exemplary works include the identification
of “risk ROH” for schizophrenia (95) and adult height (96).
Tools such as LOHAS (97), which use either whole-genome
sequence or genotype data in cohorts of either related or
unrelated individuals, are now available for performing WGH
association tests under the study designs for both case–control
and quantitative trait association tests.
Case for Family-Based Genetic
Association Studies in Arab Population
The large number of T2DM genetic loci identified to date using
unrelated people explains only a relatively small proportion
of observed heritability (familial clustering) of T2DM (8, 98).
Possible explanations for “missing heritability” may originate
from the role of rare variants, copy number variants, indels and
more complex rearrangements, gene-environment interactions
and epigenetics (98–102). Family-based designs allow the
segregation of rare variants in a pedigree; multiple copies
of such rare variants facilitate the detection of their effects.
Family-based studies require a fewer number of samples than
population-based studies and offer advantages in terms of quality
control, robustness to population stratification, and uniformity
in exposure to environmental factors or lineage-specific diseases.
They offer the potential to combine linkage and association
data. Arab population, which is largely consanguineous, offers
a large potential for family-based designs as the population can
show familial gene clustering for diabetes and metabolic traits.
However, except for few studies, such as the “Oman Family
Study” (103–106) and the study on an extended family from
the UAE by Al Safar et al. (22), no notable familial study for
diabetes risk loci has been reported on the Arab population. Both
the abovementioned studies confirmedwell-established gene loci,
but failed to identify any novel “rare” variants. Considerable
attention needs to be paid to appropriate study designs as
family data continue to provide important information in the
search for trait loci (107). It is ideal if the recruitment of large-
pedigrees/extended families, particularly those containing several
sub-families suitable for both parent-offspring design or for
sibling design, with high inbreeding and roots traceable up to at
least six generations with deduced consanguinity data is possible.
Epigenetic Mechanisms of T2DM Genetic
Risk Factors and Environmental Factors in
Arab Population
As mentioned earlier, the post-oil era witnessed in Arab
population a rapid shift in the eating and physical activity
habits. Environmental and lifestyle factors (including diet,
obesity, physical activity, tobacco smoking and environmental
pollutants) can influence epigenetic mechanisms, such as DNA
methylation, histone acetylation, and microRNA expression;
these modifications can result in altered gene expression
with effects on regulation of specific genes. Epigenome-wide
association studies (EWASs) that examine the role of epigenetic
modifications in the etiology and progression of metabolic
disorders (108–112) and diabetes (113–116) have recently
emerged. Most of such EWASs with T2D and obesity are focused
on Caucasian populations; however, a study emerged recently on
Arab population from Qatar (117), which identified one novel
CpG association at DQX1 at genome-wide significance for T2D
and replicated eight previously reported associations involving
FIGURE 2 | An integrative approach as direction of future T2DM genetics research in Arab populations. EWAS, epigenome-wide association studies; GWAS,
genome-wide association studies; WGS, whole-genome sequencing; miR-Eqtl, microRNA expression quantitative trait loci; meQTL, methylation quantitative trait loci;
eQTL, expression quantitative trait loci; CNV, copy number variation; SNP, single nucleotide polymorphism.
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TXNIP for T2D and SOCS3, SREBF1, SBNO2, CPT1A, PRR5L,
LY6G6E, and an intergenic region on chromosome 17 for BMI
albeit at suggestive p-values.
AN INTEGRATIVE APPROACH AS
DIRECTION OF FUTURE T2DM GENETICS
RESEARCH IN ARAB POPULATIONS
It has increasingly become evident that epigenetics, genetics, and
environment are likely to interact with one another to define
an individual’s risk of diabetes and obesity (118). Integration
of data on expression quantitative trait loci (eQTL), which
represent regulatory loci, with genetic variants identified from
GWA studies can give new insights into identification of
causal genes for T2DM (119, 120). The ability of epigenetic
modifications and expression of miRNA (and largely the non-
coding RNAs) to manipulate gene expression has enabled
incorporation of such data in research on pathogenesis of T2DM
(121–123). Consideration of expression data and epigenome data
along with large-scale GWA data on genotyped and imputed
SNPs and copy number variations in association studies for
T2DM is depicted as future directions for diabetes research
(Figure 2).
CONCLUSION
The failure to convincingly replicate a large number of Euro-
centric risk variants for T2DM in Arab populations may
have resulted from several aspects, including study design and
strength, low prevalence of causative Euro-centric risk variants in
the Arab population, or from the gene–environment interactions
that masked the effect of the Euro-centric risk variants. However,
epidemiological studies have illustrated the deficit of global
risk assessment tools fitted to the Arab population (124). The
performance of global genetic risk assessment tools (based on
Euro-centric markers) in other populations is also questionable
(125). The discrepancy of marker relevance in the applicability
of Euro-centric genetic risk variants to Arab population could
be resolved by performing large-scale genome-wide surveys (a
combination of GWAS, exome, and genome sequencing and
imputation) of the Arab population with diabetes. Detailed
functional assessments of loci identified in the Arab population
to interact with Euro-centric risk loci as part of common gene
networks or physiologic processes should also be performed.
AUTHOR CONTRIBUTIONS
TT and FA-M conceptualized the study design. TT and PH
developed the manuscript. All the authors participated in
discussions. JA, MA-F, JT, and FA-M critically reviewed the
manuscript.
FUNDING
The study was funded by the Kuwait Foundation for
Advancement of the Sciences (KFAS) (Dasman Diabetes
Institute project number RA 2016-026).
SUPPLEMENTARY MATERIAL




1. ALNohair S. Obesity in gulf countries. Int J Health Sci. (2014) 8:79–83.
doi: 10.12816/0006074
2. Badran M, Laher I. Obesity in arabic-speaking countries. J Obes. (2011)
2011:686430. doi: 10.1155/2011/686430
3. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C,
et al. Global, regional, and national prevalence of overweight and obesity
in children and adults during 1980–2013: a systematic analysis for
the Global Burden of Disease Study 2013. Lancet (2014) 384:766–81.
doi: 10.1016/S0140-6736(14)60460-8
4. Channanath AM, Farran B, Behbehani K, Thanaraj TA. State of diabetes,
hypertension, and comorbidity in Kuwait: showcasing the trends as seen
in native versus expatriate populations. Diabetes Care (2013) 36:e75.
doi: 10.2337/dc12-2451
5. Klautzer L, Becker JS, Mattke S. The curse of wealth - Middle Eastern
countries need to address the rapidly rising burden of diabetes.
Int J Health Pol Manag. (2014) 2:109–14. doi: 10.15171/ijhpm.
2014.33
6. Ansarimoghaddam A, Adineh HA, Zareban I, Iranpour S, HosseinZadeh A,
Kh F. Prevalence of metabolic syndrome in Middle-East countries: meta-
analysis of cross-sectional studies. Diabet Metabol Syndr. (2018) 12:195–201.
doi: 10.1016/j.dsx.2017.11.004
7. Meo SA, Usmani AM, Qalbani E. Prevalence of type 2 diabetes in the Arab
world: impact of GDP and energy consumption. Eur Rev Med Pharmacol Sci.
(2017) 21:1303–12.
8. Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW,
et al. Fine-mapping type 2 diabetes loci to single-variant resolution using
high-density imputation and islet-specific epigenome maps. Nat Genet.
(2018) 50:1505–13. doi: 10.1038/s41588-018-0241-6
9. Li-Gao R,Wakil SM,Meyer BF, Dzimiri N,Mook-Kanamori DO. Replication
of Type 2 diabetes-associated variants in a Saudi Arabian population. Physiol
Genom. (2018) 50:296–7. doi: 10.1152/physiolgenomics.00100.2017
10. Osman W, Tay GK, Alsafar H. Multiple genetic variations confer risks for
obesity and type 2 diabetes mellitus in arab descendants fromUAE. Int J Obes
. (2018) 42:1345–53. doi: 10.1038/s41366-018-0057-6
11. Cauchi S, Ezzidi I, El Achhab Y, Mtiraoui N, Chaieb L, Salah D, et al.
European genetic variants associated with type 2 diabetes in North
African Arabs. Diab Metabol. (2012) 38:316–23. doi: 10.1016/j.diabet.2012.
02.003
12. O’Beirne SL, Salit J, Rodriguez-Flores JL, Staudt MR, Abi Khalil C, Fakhro
KA, et al. Type 2 diabetes risk allele loci in the qatari population. PLoS ONE
(2016) 11:e0156834. doi: 10.1371/journal.pone.0156834
13. Al-Daghri NM, Alkharfy KM, Alokail MS, Alenad AM, Al-Attas OS,
Mohammed AK, et al. Assessing the contribution of 38 genetic loci to the risk
of type 2 diabetes in the Saudi Arabian population. Clin Endocrinol. (2014)
80:532–7. doi: 10.1111/cen.12187
14. Tomei S, Mamtani R, Al Ali R, Elkum N, Abdulmalik M, Ismail A, et al.
Obesity susceptibility loci in Qataris, a highly consanguineous Arabian
population. J Transl Med. (2015) 13:119. doi: 10.1186/s12967-015-0459-3
15. Almawi WY, Nemr R, Keleshian SH, Echtay A, Saldanha FL, AlDoseri FA,
et al. A replication study of 19 GWAS-validated type 2 diabetes at-risk
Frontiers in Endocrinology | www.frontiersin.org 10 January 2019 | Volume 10 | Article 8
Hebbar et al. Genetics of Diabetes in Arabs
variants in the Lebanese population.Diabet Res Clin Prac. (2013) 102:117–22.
doi: 10.1016/j.diabres.2013.09.001
16. Al-Sinani S, Woodhouse N, Al-Mamari A, Al-Shafie O, Al-Shafaee M,
Al-Yahyaee S, et al. Association of gene variants with susceptibility
to type 2 diabetes among Omanis. World J Diabet. (2015) 6:358–66.
doi: 10.4239/wjd.v6.i2.358
17. Mtiraoui N, Turki A, Nemr R, Echtay A, Izzidi I, Al-Zaben GSN,
et al. Contribution of common variants of ENPP1, IGF2BP2, KCNJ11,
MLXIPL, PPARgamma, SLC30A8 and TCF7L2 to the risk of type 2
diabetes in Lebanese and Tunisian Arabs. Diab Metabol. (2012) 38:444–9.
doi: 10.1016/j.diabet.2012.05.002
18. El Hajj Chehadeh SW, Jelinek HF, Al Mahmeed WA, Tay GK, Odama
UO, Elghazali GE, et al. Relationship between MTHFR C677T and A1298C
gene polymorphisms and complications of type 2 diabetes mellitus in an
Emirati population. Meta Gene (2016) 9:70-5. doi: 10.1016/j.mgene.2016.0
4.002
19. Al-Safar H, Hassoun A, Almazrouei S, Kamal W, Afandi B, Rais N.
Association of the Genetic polymorphisms in transcription factor 7-Like
2 and peroxisome proliferator-activated receptors- gamma 2 with Type 2
diabetes mellitus and is interaction with obesity status in emirati population.
J Diab Res. (2015) 2015:129695. doi: 10.1155/2015/129695
20. Khan SM, El Hajj Chehadeh S, Abdulrahman M, Osman W, Al Safar H.
Establishing a genetic link between FTO and VDR gene polymorphisms
and obesity in the Emirati population. BMC Med Genet. (2018) 19:11.
doi: 10.1186/s12881-018-0522-z
21. Ghassibe-Sabbagh M, Haber M, Salloum AK, Al-Sarraj Y, Akle Y, Hirbli
K, J. et al. T2DM GWAS in the Lebanese population confirms the role
of TCF7L2 and CDKAL1 in disease susceptibility. Sci Rep. (2014) 4:7351.
doi: 10.1038/srep07351
22. Al Safar HS, Cordell HJ, Jafer O, Anderson D, Jamieson SE, Fakiola M, et al.
A genome-wide search for type 2 diabetes susceptibility genes in an extended
Arab family. Ann Hum Genet (2013) 77:488–503. doi: 10.1111/ahg.12036
23. Zadjali F, Al-Yahyaee S, Hassan MO, Albarwani S, Bayoumi RA.
Association of adiponectin promoter variants with traits and clusters of
metabolic syndrome in Arabs: family-based study. Gene (2013) 527:663–9.
doi: 10.1016/j.gene.2013.06.057
24. Hebbar P, Nizam R, MelhemM, Alkayal F, ElkumN, John SE, et al. Genome-
wide association study identifies novel recessive genetic variants for high TGs
in an Arab population. J Lipid Res. (2018). doi: 10.1194/jlr.P080218
25. Hebbar P, Alkayal F, Nizam R, Melhem M, Elkum N, John SE, et al. The
TCN2 variant of rs9606756 [Ile23Val] acts as risk loci for obesity-related
traits and mediates by interacting with Apo-A1.Obesity (2017) 25:1098–108.
doi: 10.1002/oby.21826
26. Hebbar P, Elkum N, Alkayal F, John SE, Thanaraj TA, Alsmadi O. Genetic
risk variants for metabolic traits in Arab populations. Sci Rep. (2017) 7:40988.
doi: 10.1038/srep40988
27. Alsmadi O, MelhemM, Hebbar P, Thareja G, John SE, Alkayal F, et al. Leptin
in association with common variants of MC3R mediates hypertension. Am J
Hyperten. (2014) 27:973–81. doi: 10.1093/ajh/hpt285
28. Soliman AT, De Sanctis V, Elalaily R, Yassin M. Insulin-like growth factor-
I and factors affecting it in thalassemia major. Indian J Endocrinol Metabol.
(2015) 19:245–51. doi: 10.4103/2230-8210.131750
29. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S,
et al., Discovery and refinement of loci associated with lipid levels.Nat Genet.
(2013) 45:1274–83. doi: 10.1038/ng.2797
30. Spracklen CN, Chen P, Kim YJ, Wang X, Cai H, Li S, et al. Association
analyses of East Asian individuals and trans-ancestry analyses with European
individuals reveal new loci associated with cholesterol and triglyceride levels.
HumMol Genet. (2017) 26:1770–84. doi: 10.1093/hmg/ddx062
31. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, et al.
Newly identified loci that influence lipid concentrations and risk of coronary
artery disease. Nat Genet. (2008) 40:161–9. doi: 10.1038/ng.76
32. Ridker PM, Pare G, Parker AN, Zee RY, Miletich JP, Chasman DI.
Polymorphism in the CETP gene region, HDL cholesterol, and risk of future
myocardial infarction: genomewide analysis among 18 245 initially healthy
women from the Women’s Genome Health Study. Circul Cardiovasc Genet.
(2009) 2:26–33. doi: 10.1161/CIRCGENETICS.108.817304
33. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson
AU, et al., New genetic loci implicated in fasting glucose homeostasis
and their impact on type 2 diabetes risk. Nat Genet. (2010) 42:105–16.
doi: 10.1038/ng.520
34. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P,
et al., Genetic variation in GIPR influences the glucose and insulin responses
to an oral glucose challenge.Nat Genet. (2010) 42:142–8. doi: 10.1038/ng.521
35. Heid IM, Boes E, Muller M, Kollerits B, Lamina C, Coassin S,
et al. Genome-wide association analysis of high-density lipoprotein
cholesterol in the population-based KORA study sheds new light
on intergenic regions. Circul Cardiovasc Genet. (2008) 1: 10–20.
doi: 10.1161/CIRCGENETICS.108.776708
36. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wagele B, et al.
Human metabolic individuality in biomedical and pharmaceutical research.
Nature (2011) 477:54–60. doi: 10.1038/nature10354
37. Saxena R, Plenge RM, Bjonnes AC, Dashti HS, Okada Y, Gad El HaqW, et al.
A multinational arab genome-wide association study identifies new genetic
associations for rheumatoid arthritis. Arthritis Rheumatol. (2017) 69:976–85.
doi: 10.1002/art.40051
38. Wakil SM, Ram R, Muiya NP, Mehta M, Andres E, Mazhar N, et al. A
genome-wide association study reveals susceptibility loci for myocardial
infarction/coronary artery disease in Saudi Arabs. Atherosclerosis (2016)
245:62–70. doi: 10.1016/j.atherosclerosis.2015.11.019
39. Shan J, Al-Rumaihi K, Rabah D, Al-Bozom I, Kizhakayil D, Farhat K,
et al. Genome scan study of prostate cancer in Arabs: identification
of three genomic regions with multiple prostate cancer susceptibility
loci in Tunisians. J Transl Med. (2013) 11:121. doi: 10.1186/1479-5876-
11-121
40. Shan J, MahfoudhW, Dsouza SP, Hassen E, Bouaouina N, Abdelhak SA, et al.
Genome-wide association studies (GWAS) breast cancer susceptibility loci in
Arabs: susceptibility and prognostic implications in Tunisians. Breast Cancer
Res Treat. (2012) 135:715–24. doi: 10.1007/s10549-012-2202-6
41. Abuyassin B, Laher I. Obesity-linked diabetes in the Arab world: a review.
East Mediterr Health J. (2015) 21:420–39. doi: 10.26719/2015.21.6.420
42. Alkhateeb A, Al-Azzam S, Zyadine R, Abuarqoub D. Genetic association of
adiponectin with type 2 diabetes in Jordanian Arab population. Gene (2013)
512:61–3. doi: 10.1016/j.gene.2012.09.095
43. Mtiraoui N, Ezzidi I, Turki A, Chaieb A, Mahjoub T, Almawi WY.
Single-nucleotide polymorphisms and haplotypes in the adiponectin gene
contribute to the genetic risk for type 2 diabetes in Tunisian Arabs. Diabetes
Res Clin Pract. (2012) 97:290–7. doi: 10.1016/j.diabres.2012.02.015
44. Al-Daghri NM, Alkharfy KM, Al-Attas OS, Krishnaswamy S, Mohammed
AK, Albagha OM, et al. Association between type 2 diabetes mellitus-related
SNP variants and obesity traits in a Saudi population. Mol Biol Rep. (2014)
41:1731–40. doi: 10.1007/s11033-014-3022-z
45. Al-Awadi SA, Moussa MA, Naguib KK, Farag TI, Teebi AS, el-Khalifa M.
et al. Consanguinity among the Kuwaiti population. Clin Genet. (1985)
27:483–6. doi: 10.1111/j.1399-0004.1985.tb00236.x
46. Warsy AS, Al-Jaser MH, Albdass A, Al-Daihan S, Alanazi M. Is
consanguinity prevalence decreasing in Saudis?: a study in two generations.
African Health Sci. (2014) 14:314–21. doi: 10.4314/ahs.v14i2.5
47. Gosadi IM, Goyder EC, Teare MD. Investigating the potential effect of
consanguinity on type 2 diabetes susceptibility in a Saudi population. Hum
Heredity. (2014) 77:197–206. doi: 10.1159/000362447
48. Bener A, Hussain R. Consanguineous unions and child health in
the State of Qatar. Paediatr Perinat Epidemiol. (2006) 20:372–8.
doi: 10.1111/j.1365-3016.2006.00750.x
49. Benrahma H, Arfa I, Charif M, Bounaceur S, Eloualid A, Boulouiz
R, et al. Maternal effect and familial aggregation in a type 2
diabetic Moroccan population. J Commun Health (2011) 36:943–8.
doi: 10.1007/s10900-011-9393-3
50. Arfa I, Abid A, Malouche D, Ben Alaya N, Azegue TR, Mannai I, et al.
Familial aggregation and excess maternal transmission of type 2 diabetes in
Tunisia. Postgrad Med J. (2007) 83:348–51. doi: 10.1136/pgmj.2006.053744
51. Al-Sinani S, Al-Shafaee M, Al-Mamari A, Woodhouse N, Al-Shafie O,
Hassan M, et al. Familial clustering of type 2 diabetes among omanis. Oman
Med J. (2014) 29:51–4. doi: 10.5001/omj.2014.11
Frontiers in Endocrinology | www.frontiersin.org 11 January 2019 | Volume 10 | Article 8
Hebbar et al. Genetics of Diabetes in Arabs
52. Bener A, Yousafzai MT, Al-Hamaq AO, Mohammad AG, Defronzo RA.
Parental transmission of type 2 diabetes mellitus in a highly endogamous
population.World J Diabetes 4 (2013) 40–6. doi: 10.4239/wjd.v4.i2.40
53. Blair DR, Lyttle CS, Mortensen JM, Bearden CF, Jensen AB, Khiabanian
H, et al. A non-degenerate code of deleterious variants in Mendelian
loci contributes to complex disease risk. Cell (2013) 155:70–80.
doi: 10.1016/j.cell.2013.08.030
54. De Sanctis V, Zurlo MG, Senesi E, Boffa C, Cavallo L, Di Gregorio F.
Insulin dependent diabetes in thalassaemia.Arch Dis childh. (1988) 63:58–62.
doi: 10.1136/adc.63.1.58
55. Podolsky S, Leopold NA, Sax DS. Increased frequency of diabetes
mellitus in patients with Huntington’s chorea. Lancet (1972) 1:1356–8.
doi: 10.1016/S0140-6736(72)91092-6
56. Ristow M. Neurodegenerative disorders associated with diabetes mellitus.
J Mol Med. (2004) 82:510–29. doi: 10.1007/s00109-004-0552-1
57. Cutting GR. Modifier genes in mendelian disorders: the
example of cystic fibrosis. Ann NY Acad Sci. (2010) 1214:57–69.
doi: 10.1111/j.1749-6632.2010.05879.x
58. Hu Y, Liang J, Yu S. High prevalence of diabetes mellitus in a five-generation
Chinese family with Huntington’s disease. J Alzheimer’s Dis. (2014) 40:863–8.
doi: 10.3233/JAD-131847
59. Amberger J, Bocchini CA, Scott AF, HamoshA.McKusick’s onlinemendelian
inheritance in man (OMIM). Nucleic Acids Res. (2009) 37:D793–6.
doi: 10.1093/nar/gkn665
60. Al-Gazali L, Hamamy H. Consanguinity and dysmorphology in Arabs.Hum
Heredity (2014) 77:93–107. doi: 10.1159/000360421
61. Bo-Abbas Y, Acierno JS, Shagoury JK, CrowleyWF, Seminara SB. Autosomal
recessive idiopathic hypogonadotropic hypogonadism: genetic analysis
excludes mutations in the gonadotropin-releasing hormone (GnRH) and
GnRH receptor genes. J Clin Endocrinol Metabol. (2003) 88:2730–7.
doi: 10.1210/jc.2002-021948
62. Al Hayek AA, Khader YS, Jafal S, Khawaja N, Robert AA, Ajlouni
K. Prevalence of low testosterone levels in men with type 2 diabetes
mellitus: a cross-sectional study. J Fam Commun Med. (2013) 20:179–86.
doi: 10.4103/2230-8229.122006
63. Chaleby K, Tuma TA. Cousin marriages and schizophrenia in Saudi Arabia.
Br J Psychiatr (1987) 150:547–9. doi: 10.1192/bjp.150.4.547
64. Lin PI, Shuldiner AR. Rethinking the genetic basis for comorbidity of
schizophrenia and type 2 diabetes. Schizophr Res. (2010) 123:234–43.
doi: 10.1016/j.schres.2010.08.022
65. Shaltout TE, Alali KA, Bushra S, Alkaseri AM, Jose ED, Al-Khainji M,
et al. Significant association of close homologue of L1 gene polymorphism
rs2272522 with schizophrenia in Qatar. Asia Pac Psychiatry (2013) 5:17–23.
doi: 10.1111/appy.12014
66. Pankow JS, Decker PA, Berardi C, Hanson NQ, Sale M, Tang W, et al.
Circulating cellular adhesion molecules and risk of diabetes: the Multi-
Ethnic Study of Atherosclerosis (MESA). Diabet Med. (2016) 33:985–91.
doi: 10.1111/dme.13108
67. Hippisley-Cox J, Coupland C. Development and validation of QDiabetes-
2018 risk prediction algorithm to estimate future risk of type 2 diabetes:
cohort study. BMJ (2017) 359:j5019. doi: 10.1136/bmj.j5019
68. Visscher PM,Wray NR, Zhang Q, Sklar P, McCarthy MI, BrownMA, Yang J.
10 Years of GWAS discovery: biology, function, and translation. Am J Hum
Genet. (2017) 101:5–22. doi: 10.1016/j.ajhg.2017.06.005
69. El-Azami-El-Idrissi M, Lakhdar-Idrissi M, Ouldim K, Bono W, Amarti-Riffi
A, Hida M, et al. Improving medical research in the Arab world. Lancet
(2013) 382:2066–7. doi: 10.1016/S0140-6736(13)62692-6
70. El Obaid Y, Al Hamiz A, Abdulle A, Hayes RB, Sherman S, Ali R. Perceptions
and attitudes towards medical research in the United Arab Emirates: results
from the Abu Dhabi Cohort Study (ADCS) focus group discussions. PLoS
ONE (2016) 11:e0149609. doi: 10.1371/journal.pone.0149609
71. Pfeiffer RM, Gail MH. Sample size calculations for population- and
family-based case-control association studies on marker genotypes. Genet
Epidemiol. (2003) 25:136–48. doi: 10.1002/gepi.10245
72. Hong EP, Park JW. Sample size and statistical power calculation
in genetic association studies. Genom Info. (2012) 10:117–22.
doi: 10.5808/GI.2012.10.2.117
73. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage
and association genetic mapping studies of complex traits. Bioinformatics
(2003) 19:149–50. doi: 10.1093/bioinformatics/19.1.149
74. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient
than replication-based analysis for two-stage genome-wide association
studies. Nat Genet (2006) 38:209–13. doi: 10.1038/ng1706
75. Gauderman WJ. Sample size requirements for association studies
of gene-gene interaction. Am J Epidemiol. (2002) 55:478–84.
doi: 10.1093/aje/155.5.478
76. Alsmadi O, Thareja G, Alkayal F, Rajagopalan R, John SE, Hebbar P, et al.
Genetic substructure of Kuwaiti population reveals migration history. PLoS
ONE (2013) 8:e74913. doi: 10.1371/journal.pone.0074913
77. Alsmadi O, John SE, Thareja G, Hebbar P, Antony D, Behbehani K, et al.
Genome at juncture of early human migration: a systematic analysis of two
whole genomes and thirteen exomes from Kuwaiti population subgroup
of inferred Saudi Arabian tribe ancestry. PLoS ONE (2014) 9:e99069.
doi: 10.1371/journal.pone.0099069
78. Thareja G, John SE, Hebbar P, Behbehani K, Thanaraj TA, Alsmadi
O. Sequence and analysis of a whole genome from Kuwaiti
population subgroup of Persian ancestry. BMC Genom. (2015) 16:92.
doi: 10.1186/s12864-015-1233-x
79. John SE, Thareja G, Hebbar P, Behbehani K, Thanaraj TA, Alsmadi
O. Kuwaiti population subgroup of nomadic bedouin ancestry-
whole genome sequence and analysis. Genom Data (2015) 3:116–27.
doi: 10.1016/j.gdata.2014.11.016
80. Hunter-Zinck H, Musharoff S, Salit J, Al-Ali KA, Chouchane L, Gohar A,
et al. Population genetic structure of the people of Qatar. Am J Hum Genet.
(2010) 87:17–25. doi: 10.1016/j.ajhg.2010.05.018
81. Adriaanse MC, Drewes HW, van der Heide I, Struijs JN, Baan CA. The
impact of comorbid chronic conditions on quality of life in type 2 diabetes
patients. Qual Life Res. (2016) 25:175–82. doi: 10.1007/s11136-015-1061-0
82. Piette JD, Kerr EA. The impact of comorbid chronic
conditions on diabetes care. Diabetes Care (2006) 29:725–31.
doi: 10.2337/diacare.29.03.06.dc05-2078
83. Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, et al. Gleeson,
characterization of greater middle eastern genetic variation for enhanced
disease gene discovery. Nat Genet. (2016) 48:1071–6. doi: 10.1038/ng.3592
84. Tadmouri GO, Al Ali MT, Al-Haj Ali S, Al Khaja N. CTGA: the database for
genetic disorders in Arab populations. Nucleic Acids Res. (2006) 34:D602–6.
doi: 10.1093/nar/gkj015
85. Beasley TM, Erickson S, Allison DB. Rank-based inverse normal
transformations are increasingly used, but are they merited? Behav
Genet. (2009) 39:580–95. doi: 10.1007/s10519-009-9281-0
86. Buzkova P. Linear regression in genetic association studies. PLoS ONE (2013)
8:e56976. doi: 10.1371/journal.pone.0056976
87. Teebi AS. Autosomal recessive disorders among Arabs: an overview from
Kuwait. J Med Genet. (1994) 1:224–33. doi: 10.1136/jmg.31.3.224
88. Alexander DH, Novembre J, Lange K. Fast model-based estimation
of ancestry in unrelated individuals. Genome Res. (2009) 19:1655–64.
doi: 10.1101/gr.094052.109
89. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D.
Principal components analysis corrects for stratification in genome-wide
association studies. Nat Genet. (2006) 38:904–9. doi: 10.1038/ng1847
90. Loh PR, Tucker G, Bulik-Sullivan BK, Vilhjalmsson BJ, Finucane HK, Salem
RM, et al. Efficient Bayesian mixed-model analysis increases association
power in large cohorts. Nat Genet. (2015) 47:284–90. doi: 10.1038/ng.3190
91. Lippert C, Listgarten J, Liu Y, Kadie CM, Davidson RI, Heckerman D.
FaST linear mixed models for genome-wide association studies.Nat Methods
(2011) 8:833–5. doi: 10.1038/nmeth.1681
92. Kang HM, Sul JH, Service SK, Zaitlen NA, Kong SY, Freimer NB, et al.
Variance component model to account for sample structure in genome-
wide association studies. Nat Genet. (2010) 42:348–54. doi: 10.1038/
ng.548
93. Soranzo N. Genetic determinants of variability in glycated hemoglobin
[HbA(1c] in humans: review of recent progress and prospects
for use in diabetes care. Curr Diabet Rep. (2011) 11:562–9.
doi: 10.1007/s11892-011-0232-9
Frontiers in Endocrinology | www.frontiersin.org 12 January 2019 | Volume 10 | Article 8
Hebbar et al. Genetics of Diabetes in Arabs
94. Ku CS, Naidoo N, Teo SM, Pawitan Y. Regions of homozygosity and
their impact on complex diseases and traits. Hum Genet. (2011)129:1–15.
doi: 10.1007/s00439-010-0920-6
95. Lencz T, Lambert C, DeRosse P, Burdick KE,Morgan TV, Kane JM, et al. Runs
of homozygosity reveal highly penetrant recessive loci in schizophrenia. Proc
Natl Acad Sci USA (2007) 104:19942–7. doi: 10.1073/pnas.0710021104
96. Yang TL, Guo Y, Zhang LS, Tian Q, Yan H, Papasian CJ, et al. Runs of
homozygosity identify a recessive locus 12q21.31 for human adult height.
J Clin Endocrinol Metabol. (2010) 95:3777–82. doi: 10.1210/jc.2009-1715
97. Yang HC, Li HW. Analysis of homozygosity disequilibrium
using whole-genome sequencing data. BMC Proc. (2014) 8:S15.
doi: 10.1186/1753-6561-8-S1-S15
98. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ,
et al. Finding the missing heritability of complex diseases. Nature (2009)
461:747–53. doi: 10.1038/nature08494
99. Cousminer DL, Grant SFA. Public resources aid diabetes gene discovery. Nat
Genet (2018) 50:1499–500. doi: 10.1038/s41588-018-0242-5
100. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH.
Missing heritability and strategies for finding the underlying causes of
complex disease. Nat Rev Genet. (2010) 11:446–50. doi: 10.1038/nrg2809
101. Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet.
(2012) 13:135–45. doi: 10.1038/nrg3118
102. Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing
heritability: genetic interactions create phantom heritability. Proc Natl Acad
Sci USA (2012) 109:1193–8. doi: 10.1073/pnas.1119675109
103. Riad B, Al-Yahyaee S, Albarwani S, Jaju D, Comuzzie A, Lopez-Alvarenga J,
et al. Chapter 4: Some Genetic Determinants of Obesity, Type 2 Diabetes and
Dyslipidemias in Oman Family Study. Dubai: CTGA (2008).
104. Hassan MO, Albarwani S, Al Yahyaee S, Al Haddabi S, Rizwi S, Jaffer A, et al.
A family study in Oman: large, consanguineous, polygamous Omani Arab
pedigrees. Commun Genet. (2005) 8:56–60. doi: 10.1159/000083341
105. Bayoumi RA, Al-Yahyaee SA, Albarwani SA, Rizvi SG, Al-Hadabi S, Al-
Ubaidi FF, et al. Heritability of determinants of the metabolic syndrome
among healthy Arabs of the Oman family study. Obesity (2007) 15:551–6.
doi: 10.1038/oby.2007.555
106. Hassan MO, Jaju D, Albarwani S, Al-Yahyaee S, Al-Hadabi S, Lopez-
Alvarenga JC, et al. Non-dipping blood pressure in the metabolic syndrome
among Arabs of the Oman family study. Obesity (2007) 15:2445–53.
doi: 10.1038/oby.2007.290
107. Wijsman EM. Family-based approaches: design, imputation, analysis, and
beyond. BMC Genet. (2016) 17(Suppl 2):9. doi: 10.1186/s12863-015-0318-5
108. Wahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, et al., Epigenome-
wide association study of body mass index, and the adverse outcomes of
adiposity. Nature (2017) 541:81–6. doi: 10.1038/nature20784
109. Kvaloy K, Page CM, Holmen TL. Epigenome-widemethylation differences in
a group of lean and obese women - A HUNT Study. Sci Rep. (2018) 8:16330.
doi: 10.1038/s41598-018-34003-8
110. Demerath EW, Guan W, Grove ML, Aslibekyan S, Mendelson M, Zhou YH,
et al. Epigenome-wide association study (EWAS) of BMI, BMI change and
waist circumference in African American adults identifiesmultiple replicated
loci. HumMol Genet. (2015) 24:4464–79. doi: 10.1093/hmg/ddv161
111. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aissi D, Wahl S, et al. DNA
methylation and body-mass index: a genome-wide analysis. Lancet (2014)
383:1990–8. doi: 10.1016/S0140-6736(13)62674-4
112. Feinberg AP, Irizarry RA, Fradin D, Aryee MJ, Murakami P, Aspelund
T, et al. Personalized epigenomic signatures that are stable over time
and covary with body mass index. Sci Transl Med. (2010) 2:49ra67.
doi: 10.1126/scitranslmed.3001262
113. Chambers JC, Loh M, Lehne B, Drong A, Kriebel J, Motta V, et al.
Epigenome-wide association of DNA methylation markers in peripheral
blood from Indian Asians and Europeans with incident type 2 diabetes:
a nested case-control study. Lancet Diab Endocrinol. (2015) 3:526–34.
doi: 10.1016/S2213-8587(15)00127-8
114. Dayeh T, Volkov P, Salo S, Hall E, Nilsson E, Olsson AH, et al.
Genome-wide DNA methylation analysis of human pancreatic islets
from type 2 diabetic and non-diabetic donors identifies candidate
genes that influence insulin secretion. PLoS Genet. (2014) 10:e1004160.
doi: 10.1371/journal.pgen.1004160
115. Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B, et al.
Genome-wide survey reveals predisposing diabetes type 2-related DNA
methylation variations in human peripheral blood. Hum Mol Genet. (2012)
21:371–83. doi: 10.1093/hmg/ddr472
116. Kulkarni H, Kos MZ, Neary J, Dyer TD, Kent JW, Goring HH, et al.
Novel epigenetic determinants of type 2 diabetes in Mexican-American
families. Hum Mol Genet. (2015) 24:5330–44. doi: 10.1093/hmg/d
dv232
117. Al Muftah WA, Al-Shafai M, Zaghlool SB, Visconti A, Tsai PC, Kumar P,
Spector T, et al. Epigenetic associations of type 2 diabetes and BMI in an
Arab population. Clin Epigenet. (2016) 8:13. doi: 10.1186/s13148-016-0177-6
118. Drong AW, Lindgren CM, McCarthy MI. The genetic and epigenetic basis
of type 2 diabetes and obesity. Clin Pharmacol Therapeut. (2012) 92:707–15.
doi: 10.1038/clpt.2012.149
119. Liang X, He A, Wang W, Liu L, Du Y, Fan Q, et al. Integrating
genome-wide association and eQTLs studies identifies the genes and
gene sets associated with diabetes. BioMed Res Int. (2017) 2017:1758636.
doi: 10.1155/2017/1758636
120. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ.
Trait-associated SNPs are more likely to be eQTLs: annotation to
enhance discovery from GWAS. PLoS Genet. (2010) 6:e1000888.
doi: 10.1371/journal.pgen.1000888
121. Kameswaran V, Bramswig NC, McKenna LB, Penn M, Schug J,
Hand NJ, et al. Epigenetic regulation of the DLK1-MEG3 microRNA
cluster in human type 2 diabetic islets. Cell Metab. (2014) 19:135–45.
doi: 10.1016/j.cmet.2013.11.016
122. Muhonen P, Holthofer H. Epigenetic and microRNA-mediated
regulation in diabetes. Nephrol Dial Transplant. (2009) 24:1088–96.
doi: 10.1093/ndt/gfn728
123. Pradhan P, Upadhyay N, Tiwari A, Singh LP. Genetic and epigenetic
modifications in the pathogenesis of diabetic retinopathy: a molecular link
to regulate gene expression. New Front Ophthalmol. (2016) 2:192–204.
doi: 10.15761/NFO.1000145
124. Farran B, Channanath AM, Behbehani K, Thanaraj TA. Predictive models
to assess risk of type 2 diabetes, hypertension and comorbidity: machine-
learning algorithms and validation using national health data fromKuwait–a
cohort study. BMJ Open (2013) 3. doi: 10.1136/bmjopen-2012-002457
125. Lyssenko V, Laakso M. Genetic screening for the risk of type 2
diabetes: worthless or valuable? Diabetes Care (2013) 36 (Suppl 2):S120–6.
doi: 10.2337/dcS13-2009
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Hebbar, Abubaker, Abu-Farha, Tuomilehto, Al-Mulla and
Thanaraj. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) and the copyright owner(s)
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Endocrinology | www.frontiersin.org 13 January 2019 | Volume 10 | Article 8
